BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 8758243)

  • 21. Interconversion of three measures of performance status: an empirical analysis.
    Ma C; Bandukwala S; Burman D; Bryson J; Seccareccia D; Banerjee S; Myers J; Rodin G; Dudgeon D; Zimmermann C
    Eur J Cancer; 2010 Dec; 46(18):3175-83. PubMed ID: 20674334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer.
    Schnadig ID; Fromme EK; Loprinzi CL; Sloan JA; Mori M; Li H; Beer TM
    Cancer; 2008 Oct; 113(8):2205-14. PubMed ID: 18780322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance status score: do patients and their oncologists agree?
    Blagden SP; Charman SC; Sharples LD; Magee LR; Gilligan D
    Br J Cancer; 2003 Sep; 89(6):1022-7. PubMed ID: 12966419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Palliative Performance Scale: cross cultural adaptation and psychometric validation for Polish hospice setting.
    Dzierżanowski T; Gradalski T; Kozlowski M
    BMC Palliat Care; 2020 Apr; 19(1):52. PubMed ID: 32321494
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concordance of Barthel Index, ECOG-PS, and Palliative Performance Scale in the assessment of functional status in patients with advanced medical diseases.
    Hernández-Quiles C; Bernabeu-Wittel M; Pérez-Belmonte LM; Macías-Mir P; Camacho-González D; Massa B; Maiz-Jiménez M; Ollero-Baturone M;
    BMJ Support Palliat Care; 2017 Sep; 7(3):300-307. PubMed ID: 28130325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance status agreement assessed by the patient and clinician in a rapid access lung cancer service: Can either predict completion of treatment?
    Collins JT; Noble S; Davies HE; Farewell D; Lester JF; Parry D; Byrne A
    Eur J Cancer Care (Engl); 2019 May; 28(3):e13004. PubMed ID: 30761639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inter-rater reliability in performance status assessment among healthcare professionals: an updated systematic review and meta-analysis.
    Chow R; Bruera E; Temel JS; Krishnan M; Im J; Lock M
    Support Care Cancer; 2020 May; 28(5):2071-2078. PubMed ID: 31900613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
    Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
    Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in physical function after palliative surgery for metastatic spinal tumor: association of the revised Tokuhashi score with neurologic recovery.
    Yamashita T; Aota Y; Kushida K; Murayama H; Hiruma T; Takeyama M; Iwamura Y; Saito T
    Spine (Phila Pa 1976); 2008 Oct; 33(21):2341-6. PubMed ID: 18827700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The correlation among patients and health care professionals in assessing functional status using the karnofsky and eastern cooperative oncology group performance status scales.
    de Borja MT; Chow E; Bovett G; Davis L; Gillies C
    Support Cancer Ther; 2004 Oct; 2(1):59-63. PubMed ID: 18628160
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prospective assessment of clinical outcomes in patients with lung cancer].
    Bonfill X; Montes J; Roqué M; Nogué M; Saigí E; Seguí MA; Blanco R; Arcusa A; Arjol A; Díaz C
    Med Clin (Barc); 2000; 114 Suppl 3():104-11. PubMed ID: 10994573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Impact of Neurosurgical Complications on Patients' Health Status: A Comparison Between Different Grades of Complications.
    Schiavolin S; Broggi M; Acerbi F; Brock S; Schiariti M; Cusin A; Visintini S; Leonardi M; Ferroli P
    World Neurosurg; 2015 Jul; 84(1):36-40. PubMed ID: 25701767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the prognostic value of ECOG-PS, mGPS and BMI/WL: Implications for a clinically important framework in the assessment and treatment of advanced cancer.
    Dolan RD; Daly L; Sim WMJ; Fallon M; Ryan A; McMillan DC; Laird BJ
    Clin Nutr; 2020 Sep; 39(9):2889-2895. PubMed ID: 31926762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of Karnofsky (KPS) and WHO (WHO-PS) performance scores in brain tumour patients: the role of clinician bias.
    Frappaz D; Bonneville-Levard A; Ricard D; Carrie S; Schiffler C; Xuan KH; Weller M
    Support Care Cancer; 2021 Apr; 29(4):1883-1891. PubMed ID: 32789684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship between two performance scales: New York Heart Association Classification and Karnofsky Performance Status Scale.
    Johnson MJ; Bland JM; Davidson PM; Newton PJ; Oxberry SG; Abernethy AP; Currow DC
    J Pain Symptom Manage; 2014 Mar; 47(3):652-8. PubMed ID: 23910628
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comorbidity and KPS are independent prognostic factors in stage I non-small-cell lung cancer.
    Firat S; Bousamra M; Gore E; Byhardt RW
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):1047-57. PubMed ID: 11958901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic Evaluation of Neurological Assessment of the Neuro-Oncology Scale in Glioblastoma Patients.
    Lee J; Park SH; Kim YZ
    Brain Tumor Res Treat; 2018 Apr; 6(1):22-30. PubMed ID: 29644808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreatment nutritional risk scores and performance status are prognostic factors in esophageal cancer patients treated with definitive chemoradiotherapy.
    Song T; Wan Q; Yu W; Li J; Lu S; Xie C; Wang H; Fang M
    Oncotarget; 2017 Nov; 8(58):98974-98984. PubMed ID: 29228742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of patients with advanced cancer using the Karnofsky performance status.
    Yates JW; Chalmer B; McKegney FP
    Cancer; 1980 Apr; 45(8):2220-4. PubMed ID: 7370963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.
    Chambless LB; Kistka HM; Parker SL; Hassam-Malani L; McGirt MJ; Thompson RC
    J Neurooncol; 2015 Jan; 121(2):359-64. PubMed ID: 25344883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.